LifeStance Health Group (NASDAQ:LFST – Get Free Report) and Chemed (NYSE:CHE – Get Free Report) are both mid-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, profitability, risk, analyst recommendations, valuation and dividends.
Profitability
This table compares LifeStance Health Group and Chemed’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| LifeStance Health Group | 0.68% | 0.65% | 0.45% |
| Chemed | 10.48% | 25.66% | 17.24% |
Analyst Recommendations
This is a summary of recent ratings and price targets for LifeStance Health Group and Chemed, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| LifeStance Health Group | 0 | 2 | 6 | 1 | 2.89 |
| Chemed | 1 | 3 | 2 | 0 | 2.17 |
Valuation & Earnings
This table compares LifeStance Health Group and Chemed”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| LifeStance Health Group | $1.42 billion | 1.73 | $9.66 million | $0.02 | 316.00 |
| Chemed | $2.53 billion | 2.00 | $265.24 million | $18.37 | 20.06 |
Chemed has higher revenue and earnings than LifeStance Health Group. Chemed is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
85.5% of LifeStance Health Group shares are held by institutional investors. Comparatively, 95.8% of Chemed shares are held by institutional investors. 3.2% of LifeStance Health Group shares are held by company insiders. Comparatively, 3.3% of Chemed shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Volatility and Risk
LifeStance Health Group has a beta of 1.11, indicating that its stock price is 11% more volatile than the S&P 500. Comparatively, Chemed has a beta of 0.46, indicating that its stock price is 54% less volatile than the S&P 500.
Summary
Chemed beats LifeStance Health Group on 9 of the 15 factors compared between the two stocks.
About LifeStance Health Group
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.
About Chemed
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
